These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9166235)

  • 1. Calculation of LDL-cholesterol by using apolipoprotein B for classification of nonchylomicronemic dyslipemia.
    Planella T; Cortés M; Martínez-Brú C; González-Sastre F; Ordóñez-Llanos J
    Clin Chem; 1997 May; 43(5):808-15. PubMed ID: 9166235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of LDL-cholesterol results calculated by using apolipoproteins A1, B or HDL-cholesterol for classification of non-chylomicron dyslipidemias].
    Szmidt-Adjid V; Campier A; Pileire B
    Ann Biol Clin (Paris); 1999 May; 57(3):345-50. PubMed ID: 10377488
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of modified Friedewald's formula with direct measurement of low-density lipoprotein cholesterol in Bangladeshi population.
    Chowdhury N; Saiedullah M; Khan MA; Rahman MR
    Bangladesh Med Res Counc Bull; 2013 Dec; 39(3):120-3. PubMed ID: 26118159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels.
    Bairaktari E; Hatzidimou K; Tzallas C; Vini M; Katsaraki A; Tselepis A; Elisaf M; Tsolas O
    Clin Biochem; 2000 Oct; 33(7):549-55. PubMed ID: 11124340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson's, Martin's and Friedewald's equations.
    Vargas-Vázquez A; Bello-Chavolla OY; Antonio-Villa NE; Mehta R; Cruz-Bautista I; Aguilar-Salinas CA
    Lipids Health Dis; 2021 May; 20(1):46. PubMed ID: 33952259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic.
    Rioja J; Ariza MJ; García-Casares N; Coca-Prieto I; Arrobas T; Muñiz-Grijalvo O; Mangas A; Ibarretxe D; Sánchez-Chaparro MÁ; Valdivielso P
    Eur J Clin Invest; 2020 Dec; 50(12):e13345. PubMed ID: 32649781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidemic patients.
    Shidfar F; Keshavarz A; Jallali M; Miri R; Eshraghian M
    Int J Vitam Nutr Res; 2003 May; 73(3):163-70. PubMed ID: 12847992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes.
    Wägner AM; Jorba O; Rigla M; Alonso E; Ordóñez-Llanos J; Pérez A
    Acta Diabetol; 2002 Dec; 39(4):215-20. PubMed ID: 12486496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of methods for measurement of apolipoprotein B and cholesterol in low-density lipoproteins.
    Vrga L; Contacos C; Li SC; Sullivan DR
    Clin Chem; 1997 Feb; 43(2):390-3. PubMed ID: 9023145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels.
    Kroon AA; van't Hof MA; Demacker PN; Stalenhoef AF
    Atherosclerosis; 2000 Oct; 152(2):519-26. PubMed ID: 10998482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinaemia.
    Durrington PN; Bolton CH; Hartog M
    Clin Chim Acta; 1978 Jan; 82(1-2):151-60. PubMed ID: 201398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.
    Tchernof A; Lamarche B; Prud'Homme D; Nadeau A; Moorjani S; Labrie F; Lupien PJ; Després JP
    Diabetes Care; 1996 Jun; 19(6):629-37. PubMed ID: 8725863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of tiao-zhi-tang on lipoprotein and apolipoprotein in hyperlipemic patients].
    Jia B; Bao L
    Zhong Xi Yi Jie He Za Zhi; 1990 Jan; 10(1):22-4, 4. PubMed ID: 2350832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.
    de Arcos F; Castelo-Branco C; Casals E; Sanllehy C; Cararach V
    J Reprod Med; 1998 Feb; 43(2):144-8. PubMed ID: 9513877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-HDL cholesterol and apolipoprotein B in the dyslipidemic classification of type 2 diabetic patients.
    Wägner AM; Pérez A; Zapico E; Ordóñez-Llanos J
    Diabetes Care; 2003 Jul; 26(7):2048-51. PubMed ID: 12832311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.